Physician profile
Rita Deeba
NPI 1912689415
$950.38
in general payments reported to CMS, 2019-2025
10 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $633 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karyopharm Therapeutics INC. | $199.99 | 2024-2025 | Xpovio |
| Janssen Biotech, INC. | $170.47 | 2024 | Tecvayli, Darzalex, Talvey |
| Genzyme Corporation | $169.89 | 2024 | |
| Pfizer INC. | $136.92 | 2025 | |
| Abbvie INC. | $127.20 | 2024 | |
| Lilly USA, LLC | $33.50 | 2025 | Jaypirca |
| Adc Therapeutics America, INC. | $29.83 | 2025 | |
| Incyte Corporation | $28.36 | 2024 | Monjuvi |
| Astrazeneca Pharmaceuticals LP | $27.28 | 2025 | Calquence |
| Celgene Corporation | $26.94 | 2025 | Reblozyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Deeba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.